Mycoses: Clinical Trials

4 trials for Mycoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 withdrawn. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Withdrawn 4
Phase 24Withdrawn 4

Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections
Phase 1 / Phase 2WithdrawnInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group2026-12-312026-08-17
Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
F901318, Caspofungin - Pulmonary Aspergillosis - Invasive, Acute Myeloid Leukemia
Phase 1 / Phase 2WithdrawnF2G Ltd2017-04-202018-02-15
Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients
human lactoferrin (hLF1-11) - Fungal Infection, Bacterial Infection
Phase 1 / Phase 2WithdrawnAM-Pharma2008-11-012015-06-30
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia
hLF1-11, Placebo - Candidaemia
Phase 1 / Phase 2WithdrawnAM-Pharma2008-07-012015-06-30

Narrower conditions

Bacterial Infections (1)  ·  Candidemia (1)  ·  HIV Infections (1)  ·  Infections (1)  ·  Invasive Pulmonary Aspergillosis (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neutropenia (1)  ·  Torulopsis (1)  ·  Tuberculosis (1)

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Infections (3)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Invasive Fungal Infections (2)  ·  Actinomycetales Infections (1)  ·  Agranulocytosis (1)  ·  Aspergillosis (1)  ·  Bacterial Infections (1)  ·  Blood-Borne Infections (1)  ·  Candidiasis (1)  ·  Candidiasis, Invasive (1)  ·  Communicable Diseases (1)  ·  Cytopenia (1)

Interventions

BCG Vaccine (1)  ·  Caspofungin (1)  ·  VPM1002 recombinant BCG vaccine (1)  ·  lactoferrin (1-11), human (1)  ·  olorofim (1)

Sponsors

AM-Pharma (2)  ·  F2G Ltd (1)  ·  International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)

Countries

Netherlands (2)  ·  South Africa (1)

Top investigators

Lisa Marie Cranmer, MD, MPH (1)  ·  Oliver Cornely, PhD, MD (1)  ·  Peter J Donnelly, PhD (1)  ·  Professor P.E. Verweij, MD, PhD (1)

NIH funding

UM1AI068616 (1), UM1AI068632 (1), UM1AI106716 (1)